5 strategies for using water-soluble cannabinoids in cannabis drinks

Extraction scientists and formulators are racing toward faster and cheaper ways to make cannabinoid molecules – hydrophobic and therefore impossible to dissolve in water – suitable for incorporating into drinks.

Canopy to buy Supreme for CA$435 million as cannabis M&A heats up

Canopy Growth announced plans to acquire competing Canadian marijuana producer The Supreme Cannabis Co. in a stock-and-cash deal valued at roughly 435 million Canadian dollars ($345 million).

Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?

Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say.

What marijuana investors can learn from GameStop trading frenzy

Last week’s meteoric rise of GameStop’s shares made headlines, but what should be made of it? And what can we learn from it for marijuana?

France chooses companies to supply free medical cannabis for trial program

The French Agency for the Safety of Medicines and Health Products (ANSM) selected the companies that will supply France’s medical cannabis pilot program that’s intended to provide free products to patients enrolled in the trial.

Cannabis industry enters 2021 with fresh markets, greater possibilities amid continuing challenges

Let’s face it: As terrible as 2020 was for numerous business sectors, it was surprisingly good for the cannabis industry in multiple ways.

Canada’s ‘croptober’ surge pushes cannabis inventory over 1 million kilograms

Canadian licensed producers added a record 220,461 kilograms of marijuana to their inventories in October 2020, according to new data offering a statistical glimpse of the country’s first large-scale “croptober” – when most of the fall outdoor harvest comes in.